Resurgence Alcohol & Drug Rehab Publishes New Clinical Resource Examining Risks of Mixing Lipitor and Alcohol

JURUPA VALLEY, CA - March 05, 2026 - PRESSADVANTAGE - Resurgence Alcohol & Drug Rehab Riverside has published a new ...

Grace Point Treatment Center Publishes New Resource on Website Discussing Coral Ridge Isles Rehab and Structured Paths to Addiction Recovery

FORT LAUDERDALE, FL - March 06, 2026 - PRESSADVANTAGE - Grace Point Treatment Center has published a new educational ...

Grace Point Treatment Center Publishes New Resource on Website Discussing Alcohol Misuse and Recovery Pathways Near Sea Ranch Lakes

FORT LAUDERDALE, FL - March 10, 2026 - PRESSADVANTAGE - Grace Point Treatment Center has released a new educational ...
TMCnet

GENFIT Receives FDA Orphan Drug Designation for NTZ for the treatment of ACLF

G1090N is GENFIT’s lead investigational program within the ACLF segment of its pipeline. The FDA’s ODD recognizes the ...
Cambs Times

Extra funding for drug and alcohol treatment in Cambs

Cambridgeshire councillors have agreed to award additional grant funding to support drug and alcohol treatment.

Moment of Clarity Publishes In-Depth Resource on Insurance Coverage for TMS Therapy, Expanding Access to Evidence-Based Mental Health Treatment

LONG BEACH, CA - March 06, 2026 - PRESSADVANTAGE - Moment of Clarity has published a comprehensive new resource on its ...
Florida Phoenix

Senate moves to save AIDS drug assistance program from DeSantis administration cuts

In a dysfunctional session that has been underscored by what one senator called an “inexcusable amount of animosity,” the ...

Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Liver Transplantation

Clinical studies in kidney transplantation have demonstrated that tegoprubart has the potential to improve graft survival and function while reducing the side effects associated with calcineurin ...
The Barre-Montpelier Times Argus

Peptilogics Begins Pivotal Trial of First-Ever Drug Designed to Cure Medical Device-Related Infections

Peptilogics' PLG0206 is a first-in-class anti-biofilm drug candidate being studied in patients with prosthetic joint ...
MedPage Today on MSN

Cancer drug pulled from market over safety concerns

Confirmatory trial on tazemetostat suggested a link with secondary hematologic malignancie ...

Oragenics Receives HREC Approval for Phase IIa Clinical Trial of ONP-002 as a Treatment for Concussion and Mild Traumatic Brain Injury in Australia

All required regulatory approvals secured for trial site onboarding and patient enrollment at three Australian sitesPotential first and only ...